Scientific Committee

The Scientific Committee is a body of the IMI Joint Undertaking (IMI JU) and provides scientific advice to the Governing Board [1]. It is currently composed of 15 members that have been appointed further to suggestions made by the States Representatives Group [2]. The Scientific Committee gives strategic science-based recommendations to the IMI JU, advises on the continued relevance of the Research Agenda [3] and the scientific priorities, which are the basis for Call Topics.

The Chair of the Scientific Committee is Christian Noe and the Co-Chair is Daan Crommelin.

Brief biographies of all current Scientific Committee members are displayed below.

Chair: Christian Noe [4]
Head of the Department of Medicinal Chemistry, University of Vienna

Co-Chair: Daan Crommelin [5]
Professor, Department of Pharmaceutics, Utrecht University

Mary Baker [6]
President, European Brain Council (EBC)

Jozef Dulak [7]
Head of the Department of Medical Biotechnology, Jagiellonian University, Krakow

Karin Forsberg-Nilsson [8]
Professor of Stem Cell Research, Uppsala University

Gerd Geisslinger [9]
Professor of Clinical Pharmacology & Chair of the Institute of Clinical Pharmacology, Johann Wolfgang Goethe University, Frankfurt am Main

Jens Heisterberg [10]
Chief Medical Officer, Danish Medicines Agency

Trevor M. Jones [11]
Director, Allergan Inc, Sigma–Tau Finanziaria SpA, tReNeuron plc, Synexus Ltd, NextPharma Technologies Ltd, and VeronaPharma plc

Carole Longson [12]
Executive Director, National Institute for Health and Clinical Excellence (NICE)

Adriana Maggi [13]
Director, Centre of Excellence on Neurodegenerative Diseases, University of Milan

Françoise Meunier [14]
Director General, European Organisation for Research and Treatment of Cancer (EORTC)

Daniele Piomelli [15]
Director, Drug Discovery and Development (D3) Research Unit, Istituto Italiano di Tecnologia (IIT); Director, Centre for Drug Discovery, University of California Irvine (UCI)

Ferran Sanz [16]
Vice-Rector and Full Professor of Biostatistics and Biomedical Informatics at the Universitat Pompeu Fabra, Barcelona

Adam Vas [17]
Professor, Szeged University of Sciences; Senior Research Adviser, Chemical Works of Gedeon Richter Plc., Budapest

Ioannis Xenarios [18]
Director, Vital-IT and Swiss-Prot group